Group items tagged

The market remained strong in morning trade with the Sensex surging 281.73 points or 1.07 percent to 26528.52 and the Nifty climbing 84.10 points or 1.07 percent to 7926.80 supported by broadbased buying. Market expert Ambareesh Baliga sees 7,800-7,750 as good support level for the Nifty. In an interview with CNBC-TV18, he said Nifty is unlikely to go much beyond 8,000 levels. He remains positive on cyclicals and expects them to become more attractive post any market correction. According to Baliga, the next leg of market rally will be led by cyclicals. The broader markets outperformed benchmarks with the BSE Midcap and Smallcap indices rising 1.4 percent each. Advancing shares outnumbered declining ones by a ratio of 1544 to 380 on the Bombay Stock Exchange. The BSE Capital Goods, Realty, Metal, Banks, Healthcare, Power and Oil & Gas indices gained 1-1.7 percent. Hindalco and BHEL kept their top positions in the buying list, up 4.8 percent and 3.5 percent, respectively. Dr Reddy's Labs, Cipla, HDFC, Bank of Baroda, Ambuja Cements and PNB surged 2-2.6 percent. However, NTPC and Bajaj Auto were only losers in the Sensex 30 stocks.

Trade4Target : Daily Updates 8/10/2014 Mkt may fall 5% further; IT still attractive - Trade4Target The current market fall is likely to fall anything between 3 to 5 percent and may find a floor at those levels, says C Jayaram, joint managing director, Kotak Mahindra Bank. Speaking to CNBC-TV18, Jayaram says the market has run up a lot post the general elections and is cooling off now. But for any rally now, the market will need some robust global or economic triggers. www.trade4target.com

The market extended its southward journey for the second trading session of the October month with the Sensex falling 296.02 points or 1.11 percent to 26271.97 on Tuesday. The Nifty closed way below the 7900, down 93.15 points or 1.17 percent to 7852.40. About 1120 shares advanced while 1762 shares declined on the BSE. Hindalco Industries, Sesa Sterlite, Cipla, Dr Reddy's Labs, HDFC, DLF, Jindal Steel and Cairn India were top losers, falling 3-6 percent while NTPC, Gail India and Power Grid bucked the trend, up 1-1.5 percent followed by Tata Motors, Wipro and Tata Power with marginal gains. Today Stock Tips Kitex Garments Limited for long term buy Cmp:338rs Target:475rs Return percentage:40% Duration:9-12 months 5 year CAGR return expected:25-30% 5 year target potential range:1031rs-1254rs Kitex Garments Ltd manufactures toddler wear for most of the international brands such as MotherCare, Toys R Us, Gerber etc and is ranked as the third largest company of such type in the world.Company also supplies to jockey.Group employees to over 8000 peeps.It is the only company in the world which uses Acutex 1 quality of input.Add up more safety features like 100% certified safe process and organic dyes using threads from the number 1 codes etc which makes it the most favorable supplier for infant clothes.The company has to its credit the Best Vendor Award from Toys R Us and Gerber for the past couple of years(among over 280 rivals).

Get Global Market Research, News, Updates, Trends, Forecasts and Analysis in various categories on Research on Global Markets Blog.

Get Global Market Research, News, Updates, Trends, Forecasts and Analysis in various categories on Research on Global Markets Blog.

Sensex slips 340 pts on global woes; Q2 nos lift Infosys 7% Sensex Down: 339 pt. Nifty Down: 100 pt. 1. Failed Circuit Filter SEBI Pulls NSE Sebi diredted nse to be carful and cautions in its dealings in the securities market and comply with all the legal requirements that govern its functions as a stock exchange. on october 5, 2012, a dealer at Emkay Global Finance has erroneously put in an order to sell a niftybasket consisting each of the 50 index constituents worth rs 950 crore, within a few seconds of the order being put into the system, nifty had crashed 16% before tradeing was stopped by the exchange. 2. Infosys posts 28% Q2 net profit Infosys yet again have done better in its second quarter and cheered investors by announcing bonus shares. Murthy wants to avoid conflicts and maintain corporate governance standards at the firm he co-founded 33 years ago. 3.Vodafone wins 3,200crore tax case Bombay high court ruled in its favour in the transfer pricing case relating to undervaluation of share capital issued by vodafone india Services Private Limited(Vodafone India) to its Mauritius parent. 4. Only limited Sahara investers claim refund from Sebi The low demand will bolester sahara's argument before courts that it had repaid most of the investers who had come forward app. 4,600 to claim investments they had made in two groups cos's bonds. Trade4target : stock to buy Shreyas Shipping & Logistics Ltd CMP:69rs Target:130rs Duration:6-10 months Percentage return:85% Shreyas Shipping & Logistics Ltd (SSLL) is a dominant multimodal container logistics operator using land-sea-land route. Their claim is they are No.1 Coastal Operator in India with 51% market share, in handling domestic coastal cargo. It is also the India's largest container feeder vessel owning and operating company & first co to link all key ports of India for containerised trade.Shreyas begun in 1994 as a container feeder operator between Indian ports and international co

Oct 15 - Indian markets are closed on Wednesday due to assembly elections in Maharashtra state. The benchmark BSE index fell 0.13 percent, or 34.74 points, to end at 26,349.33 on Tuesday. The broader NSE index lost 0.26 percent, or 20.25 points, to at 7,864.Stock exchanges will reopen tommorow on 16 Oct 2014. http://trade4targettrade4targettrade4target.blogspot.in/2014/10/trade4target-stock-updates.html

Brand History The company was founded in the year 1977 by first generation entrepreneur Mr. Kanti Parasrampuria. He has a vast work experience in the field of textiles, beverages and plastics and a profound business acumen and managerial alacrity. The company benefits from his expertise and guidance and also relies on a highly experienced and well qualified professional management team for its day to day operations. Brand Advantage The company owns a fully automatic plant to manufacture 6000 liters per hour of fruit based beverages at Mandideep near Bhopal (M.P.), India. It is a state-of-art plant with two PET blowing and filling lines, one V-Pak (aseptic juice carton) and one stand-up pouch filling line. The infrastructure is par-excellence and ensures that delicious, safe and hygienic products are delivered to the market. The beverages made by us are untouched by hand are produced under stringent conditions. The beverage division has achieved the prestigious ISO 22000:2005 including HACCP certification from the Swiss multinational certification agency SGS. The facility is also certified ISO 9001:2008 from ICS. All the equipment's used in the plant are installed by vendors that are approved by big multinational beverage companies. The raw and packaging material procured is from good quality sources which are first audited for quality. The plant is centrally located in Bhopal with very good road, air and rail link to rest of the country. Our products are currently available in 15 states of India (updated Feb 2013) and counting. Mango dash created a great deal of excitement in its category and celebrated the indulgence in mangoes like no other brand had done before. While other players have portrayed the mango as a simple and innocent fruit, Mango dash celebrates the sheer indulgence and sensuality involved in consuming a mango. The creative 'Aamsutra' idea communicates the experience of extreme sensuous pleasure through the act of drinking M

MCX Gold and silver are trading with a very minor price gain in Commodity market on Thursday. With a gain of 0.25% MCX Gold reached to the level of 30111while the silver is trading at 55132 with a gain of 0.20%. International Markets are showing a flat business in the gold and silver.

Gold in Thursday's trading met it's highest price in the history. But in the international market price is below 15 per cent to record levels. With 0.3 per cent gain MCX gold is trading at Rs 30130. While inspot market of Delhi Golf managed to reach the record price of 30,550.

The market is down. There is no sign of strength.You can buy now and sell whenever you get a weakness. Visit us now to know more. Stay tuned with us for more updates.

16 June MCX NCDEX Tips: MCX Gold Aug'12 Support - 30290,30400 Resistance - 30580,30590. MCX Silver Jul'12 Support- 54540,54911 Resistance-55430,55720 While inspot market of Delhi Golf managed to reach the record price of 30,550.

16 June MCX NCDEX Tips: MCX Gold Aug'12 Support - 30290,30400 Resistance - 30580,30590. MCX Silver Jul'12 Support- 54540,54911 Resistance-55430,55720 While inspot market of Delhi Golf managed to reach the record price of 30,550.

Summary 'Male Infertility - Pipeline Review, H2 2015', provides an overview of the Male Infertility's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Male Infertility, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

Summary 'Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2015', provides an overview of the Opioid-Induced Constipation (OIC)'s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Opioid-Induced Constipation (OIC), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

The report 'Hodgkin Lymphoma - Pipeline Review, H2 2015 ', provides an overview of the Hodgkin Lymphoma's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hodgkin Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

Summary 'Rhinovirus Infection - Pipeline Review, H2 2015', provides an overview of the Rhinovirus Infection's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Rhinovirus Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

Summary 'Down Syndrome - Pipeline Review, H2 2015', provides an overview of the Down Syndrome's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Down Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.